Collaboration will extend work to prioritize valuable novel target-effector pairs, ideal for subsequent molecular glue development, including aiming at targets previously considered undruggable through...
23andMe Holding Co. announced a new, non-exclusive data license with GSK plc which extends their collaboration and enables GSK to conduct drug target discovery...